Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy

Drug Discovery Today

Volumn 13, Issue 13-14, 2008, Pages 625-632

  Wang, Jinhai ^a   Norcross, Michael ^a  

^a Center for Drug Evaluation and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR;

CHEMOTAXIS; DIMERIZATION; DRUG RECEPTOR BINDING; METASTASIS; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; DIMERIZATION; HUMANS; RECEPTORS, CHEMOKINE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 45849143641     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.04.004     Document Type: Review

References (77)

1. Allen S.J., et al. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25 (2007) 787-820
2. Berger E.A., et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17 (1999) 657-700
3. Sallusto F., and Mackay C.R. Chemoattractants and their receptors in homeostasis and inflammation. Curr. Opin. Immunol. 16 (2004) 724-731
4. Kakinuma T., and Hwang S.T. Chemokines, chemokine receptors, and cancer metastasis. J. Leukoc. Biol. 79 (2006) 639-651
5. Proudfoot A.E. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2 (2002) 106-115
6. Johnson Z., et al. Multi-faceted strategies to combat disease by interference with the chemokine system. Trends Immunol. 26 (2005) 268-274
7. Milligan G., and Bouvier M. Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS J. 272 (2005) 2914-2925
8. Wang J., et al. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions. Mol. Cancer Ther. 5 (2006) 2474-2483
9. He L., et al. Determination of tumor necrosis factor receptor-associated factor trimerization in living cells by CFP → YFP → mRFP FRET detected by flow cytometry. Nucl. Acids Res. 33 (2005) e61
10. Fotiadis D., et al. Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 421 (2003) 127-128
11. Palczewski K., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
12. Cherezov V., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318 (2007) 1258-1265
13. Rasmussen S.G., et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
14. Rosenbaum D.M., et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 318 (2007) 1266-1273
15. Milligan G. G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol. 66 (2004) 1-7
16. Franco R., et al. Basic concepts in G-protein-coupled receptor homo- and heterodimerization. Sci. World J. 7 (2007) 48-57
17. Rodriguez-Frade J.M., et al. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3628-3633
18. Vila-Coro A.J., et al. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13 (1999) 1699-1710
19. Hernanz-Falcon P., et al. Identification of amino acid residues crucial for chemokine receptor dimerization. Nat. Immunol. 5 (2004) 216-223
20. Vila-Coro A.J., et al. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3388-3393
21. Percherancier Y., et al. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J. Biol. Chem. 280 (2005) 9895-9903
22. Issafras H., et al. Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J. Biol. Chem. 277 (2002) 34666-34673
23. Huttenrauch F., et al. G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers. J. Biol. Chem. 280 (2005) 37503-37515
24. Trettel F., et al. Ligand-independent CXCR2 dimerization. J. Biol. Chem. 278 (2003) 40980-40988
25. Wilson S., et al. The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. J. Biol. Chem. 280 (2005) 28663-28674
26. Babcock G.J., et al. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J. Biol. Chem. 278 (2003) 3378-3385
27. AbdAlla S., et al. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407 (2000) 94-98
28. Lee S.P., et al. Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J. Biol. Chem. 279 (2004) 35671-35678
29. Mellado M., et al. Chemokine control of HIV-1 infection. Nature 400 (1999) 723-724
30. Mellado M., et al. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J. 20 (2001) 2497-2507
31. Agrawal L., et al. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells. J. Virol. 78 (2004) 2277-2287
32. Guan E., et al. Identification of human macrophage inflammatory proteins 1alpha and 1beta as a native secreted heterodimer. J. Biol. Chem. 276 (2001) 12404-12409
33. Nesmelova I.V., et al. Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level. J. Biol. Chem. 280 (2005) 4948-4958
34. Crown S.E., et al. Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding. J. Biol. Chem. 281 (2006) 25438-25446
35. Jin H., et al. The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor. J. Biol. Chem. 282 (2007) 27976-27983
36. Sohy D., et al. Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J. Biol. Chem. 282 (2007) 30062-30069
37. Wu L., et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384 (1996) 179-183
38. Lapham C.K., et al. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274 (1996) 602-605
39. Xiao X., et al. Constitutive cell surface association between CD4 and CCR5. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7496-7501
40. Gaibelet G., et al. CD4 and CCR5 constitutively interact at the plasma membrane of living cells: a confocal fluorescence resonance energy transfer-based approach. J. Biol. Chem. 281 (2006) 37921-37929
41. Baker A.M., et al. CD4 interacts constitutively with multiple CCR5 at the plasma membrane of living cells. A fluorescence recovery after photobleaching at variable radii approach. J. Biol. Chem. 282 (2007) 35163-35168
42. Basmaciogullari S., et al. Specific interaction of CXCR4 with CD4 and CD8alpha: functional analysis of the CD4/CXCR4 interaction in the context of HIV-1 envelope glycoprotein-mediated membrane fusion. Virology 353 (2006) 52-67
43. Yi L., et al. HIV gp120-induced interaction between CD4 and CCR5 requires cholesterol-rich microenvironments revealed by live cell fluorescence resonance energy transfer imaging. J. Biol. Chem. 281 (2006) 35446-35453
44. Toth P.T., et al. Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. J. Pharmacol. Exp. Ther. 310 (2004) 8-17
45. Oravecz T., et al. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186 (1997) 1865-1872
46. Herrera C., et al. Comodulation of CXCR4 and CD26 in human lymphocytes. J. Biol. Chem. 276 (2001) 19532-19539
47. Klco J.M., et al. C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J. Biol. Chem. 278 (2003) 35345-35353
48. Lee S.P., et al. Homo- and hetero-oligomerization of G protein-coupled receptors. Life Sci. 74 (2003) 173-180
49. Liang Y., et al. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278 (2003) 21655-21662
50. Fotiadis D., et al. Structure of the rhodopsin dimer: a working model for G-protein-coupled receptors. Curr. Opin. Struct. Biol. 16 (2006) 252-259
51. Davies A., et al. Three-dimensional structure of an invertebrate rhodopsin and basis for ordered alignment in the photoreceptor membrane. J. Mol. Biol. 314 (2001) 455-463
52. Guo W., et al. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17495-17500
53. Hebert T.E., et al. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271 (1996) 16384-16392
54. Baneres J.L., and Parello J. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J. Mol. Biol. 329 (2003) 815-829
55. Lodowski D.T., et al. Crystal packing analysis of rhodopsin crystals. J. Struct. Biol. 158 (2007) 455-462
56. Terrillon S., et al. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol. Endocrinol. 17 (2003) 677-691
57. Herrick-Davis K., et al. Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer. J. Biol. Chem. 281 (2006) 27109-27116
58. Zhang Y., et al. Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells 22 (2004) 1015-1029
59. Franca-Koh J., et al. Leading-edge research: PtdIns(3,4,5)P3 and directed migration. Nat. Cell Biol. 9 (2007) 15-17
60. Chen L., et al. PLA2 and PI3K/PTEN pathways act in parallel to mediate chemotaxis. Dev. Cell 12 (2007) 603-614
61. de Gorter D.J., et al. Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing. Immunity 26 (2007) 93-104
62. Muller A., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
63. Burns J.M., et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203 (2006) 2201-2213
64. Kim J., et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J. Clin. Oncol. 23 (2005) 2744-2753
65. Yasumoto K., et al. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 66 (2006) 2181-2187
66. Liang Z., et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res. 64 (2004) 4302-4308
67. Liang Z., et al. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 65 (2005) 967-971
68. Lemay J., et al. On the dimerization of CCR5. Nat. Immunol. 6 (2005) 535-536
69. Tarasova N.I., et al. Inhibition of G-protein-coupled receptor function by disruption of transmembrane domain interactions. J. Biol. Chem. 274 (1999) 34911-34915
70. Berchiche Y.A., et al. Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation. J. Biol. Chem. 282 (2007) 5111-5115
71. Geras-Raaka E., et al. Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J. Exp. Med. 188 (1998) 405-408
72. Rosenkilde M.M., et al. Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74. J. Biol. Chem. 274 (1999) 956-961
73. Haworth B., et al. Allosteric effects of antagonists on signalling by the chemokine receptor CCR5. Biochem. Pharmacol. 74 (2007) 891-897
74. Peuchant O., et al. Primary resistance to enfuvirtide (T20) in recently HIV-1 infected, antiretroviral-naive patients from the ANRS Aquitaine Cohort. Antivir. Ther. 12 (2007) 559-562
75. Tom I., et al. Reproducible production of a PEGylated dual-acting peptide for diabetes. AAPS J. 9 (2007) E227-E234
76. Lee S., et al. PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice. Diabetologia 49 (2006) 1608-1611
77. Koh Y., et al. Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization. J. Biol. Chem. 282 (2007) 28709-28720